PHI with autoimmune hepatitis
How does this condition affect your private health insurance?
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease where the body's immune system mistakenly attacks its own liver cells. This leads to inflammation, which, if left untreated, can result in significant liver damage, including fibrosis, cirrhosis, and ultimately liver failure. It can affect people of all ages and genders, though it's more common in women. Symptoms vary from mild fatigue and joint pain to severe jaundice and ascites. Diagnosis involves blood tests for liver enzymes and autoantibodies, often confirmed by a liver biopsy. Treatment primarily involves immunosuppressive medications to reduce inflammation and prevent disease progression.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Can range from an acute, severe presentation lasting weeks to a more insidious onset recognized over several months.
Duration of Illness (Lifetime)
Chronic disease requiring lifelong management; can have periods of remission and flare-ups.
Cost of Treatment (Initial)
Moderately high (e.g., several thousands to tens of thousands of USD) for diagnosis (biopsy, imaging, lab tests) and initial immunosuppressive therapy.
Cost of Treatment (Lifetime)
High to very high (e.g., tens of thousands to hundreds of thousands of USD) due to ongoing medication, regular monitoring, management of complications, and potential liver transplantation.
Mortality Rate
Low with timely diagnosis and consistent treatment, but significantly higher (up to 50% within 5 years) if untreated or in cases of acute liver failure, or if complications like advanced cirrhosis develop.
Risk of Secondary Damages
High. Untreated or poorly controlled AIH frequently leads to cirrhosis (30-80%), liver failure, portal hypertension, and an increased risk of hepatocellular carcinoma. Psychological impact from chronic illness is also possible.
Probability of Full Recovery
Low, as it is a chronic condition. Remission is achievable with treatment, but complete eradication is rare. Lifelong medication is typically required to prevent relapse, although some patients can eventually taper off medication under strict medical supervision.
Underlying Disease Risk
Moderately high (20-40%) for other autoimmune conditions such as inflammatory bowel disease, autoimmune thyroiditis, rheumatoid arthritis, celiac disease, and type 1 diabetes.